Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
43
PHG Quote, Financials, Valuation and Earnings
Last price:
$26.49
Seasonality move
:
8.02%
Day range:
$26.49 - $26.72
52-week range:
$21.48 - $29.54
Dividend yield:
3.65%
P/E ratio:
134.93x
P/S ratio:
1.25x
P/B ratio:
2.03x
Volume:
563.9K
Avg. volume:
685.6K
1-year change:
7.2%
Market cap:
$25.2B
Revenue:
$19.5B
EPS (TTM):
$0.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$5B | $0.32 | 35.17% | 481.67% | $33.40 |
|
ARGX
argenx SE
|
$1.1B | $4.11 | 87.13% | 205.62% | $1,010.54 |
|
DBVT
DBV Technologies SA
|
$889.9K | -$0.34 | -- | -77.3% | $40.03 |
|
PRQR
ProQR Therapeutics NV
|
$7M | -$0.17 | 32.53% | -55.96% | $8.88 |
|
QURE
uniQure NV
|
$5.2M | -$0.86 | 8.51% | -38.17% | $55.30 |
|
TRIB
Trinity Biotech Plc
|
$7.5M | -$0.57 | -33.73% | -28.57% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$26.49 | $33.40 | $25.2B | 134.93x | $0.97 | 3.65% | 1.25x |
|
ARGX
argenx SE
|
$847.05 | $1,010.54 | $52.2B | 43.06x | $0.00 | 0% | 18.07x |
|
DBVT
DBV Technologies SA
|
$21.52 | $40.03 | $588.8M | -- | $0.00 | 0% | -- |
|
PRQR
ProQR Therapeutics NV
|
$2.10 | $8.88 | $221.2M | -- | $0.00 | 0% | 12.70x |
|
QURE
uniQure NV
|
$23.93 | $55.30 | $1.5B | -- | $0.00 | 0% | 81.77x |
|
TRIB
Trinity Biotech Plc
|
$0.94 | -- | $17.5M | -- | $0.00 | 0% | 0.22x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
44.81% | 0.542 | 43.45% | 0.72x |
|
ARGX
argenx SE
|
-- | 0.059 | -- | 4.92x |
|
DBVT
DBV Technologies SA
|
23.24% | -1.892 | 5.85% | 1.41x |
|
PRQR
ProQR Therapeutics NV
|
20.36% | 3.523 | 7.64% | 3.23x |
|
QURE
uniQure NV
|
69.92% | 0.547 | 14.65% | 6.94x |
|
TRIB
Trinity Biotech Plc
|
147.47% | 1.094 | 785.94% | 0.87x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PHG
Koninklijke Philips NV
|
$2.2B | $447.6M | 1% | 1.55% | 9.61% | $170.3M |
|
ARGX
argenx SE
|
$837.2M | $203.8M | 24.23% | 28.06% | 30.38% | $312.8M |
|
DBVT
DBV Technologies SA
|
-$4.3M | -$36.9M | -211.46% | -280.59% | -- | -$32.5M |
|
PRQR
ProQR Therapeutics NV
|
$2.6M | -$13.2M | -54.22% | -67.34% | -392.68% | -$15.4M |
|
QURE
uniQure NV
|
-$329K | -$50.7M | -40.98% | -382.35% | -1370.5% | -$17.7M |
|
TRIB
Trinity Biotech Plc
|
$5.3M | -$2.2M | -45.03% | -- | -11.29% | -$6.3M |
Koninklijke Philips NV vs. Competitors
-
Which has Higher Returns PHG or ARGX?
argenx SE has a net margin of 5.53% compared to Koninklijke Philips NV's net margin of 25.88%. Koninklijke Philips NV's return on equity of 1.55% beat argenx SE's return on equity of 28.06%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV46.36% $0.22 $22.1B ARGXargenx SE88.32% $3.74 $6.1B -
What do Analysts Say About PHG or ARGX?
Koninklijke Philips NV has a consensus price target of $33.40, signalling upside risk potential of 26.09%. On the other hand argenx SE has an analysts' consensus of $1,010.54 which suggests that it could grow by 19.3%. Given that Koninklijke Philips NV has higher upside potential than argenx SE, analysts believe Koninklijke Philips NV is more attractive than argenx SE.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV0 2 0 ARGXargenx SE15 2 0 -
Is PHG or ARGX More Risky?
Koninklijke Philips NV has a beta of 0.793, which suggesting that the stock is 20.74% less volatile than S&P 500. In comparison argenx SE has a beta of 0.366, suggesting its less volatile than the S&P 500 by 63.397%.
-
Which is a Better Dividend Stock PHG or ARGX?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.65%. argenx SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays 0.12% of its earnings as a dividend. argenx SE pays out -- of its earnings as a dividend. Koninklijke Philips NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PHG or ARGX?
Koninklijke Philips NV quarterly revenues are $5B, which are larger than argenx SE quarterly revenues of $948M. Koninklijke Philips NV's net income of $219.7M is lower than argenx SE's net income of $245.4M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 134.93x while argenx SE's PE ratio is 43.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.25x versus 18.07x for argenx SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.25x 134.93x $5B $219.7M ARGXargenx SE18.07x 43.06x $948M $245.4M
-
Which has Higher Returns PHG or DBVT?
DBV Technologies SA has a net margin of 5.53% compared to Koninklijke Philips NV's net margin of --. Koninklijke Philips NV's return on equity of 1.55% beat DBV Technologies SA's return on equity of -280.59%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV46.36% $0.22 $22.1B DBVTDBV Technologies SA-- -$1.21 $68.9M -
What do Analysts Say About PHG or DBVT?
Koninklijke Philips NV has a consensus price target of $33.40, signalling upside risk potential of 26.09%. On the other hand DBV Technologies SA has an analysts' consensus of $40.03 which suggests that it could grow by 86.01%. Given that DBV Technologies SA has higher upside potential than Koninklijke Philips NV, analysts believe DBV Technologies SA is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV0 2 0 DBVTDBV Technologies SA4 0 1 -
Is PHG or DBVT More Risky?
Koninklijke Philips NV has a beta of 0.793, which suggesting that the stock is 20.74% less volatile than S&P 500. In comparison DBV Technologies SA has a beta of -1.102, suggesting its less volatile than the S&P 500 by 210.179%.
-
Which is a Better Dividend Stock PHG or DBVT?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.65%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays 0.12% of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend. Koninklijke Philips NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PHG or DBVT?
Koninklijke Philips NV quarterly revenues are $5B, which are larger than DBV Technologies SA quarterly revenues of --. Koninklijke Philips NV's net income of $219.7M is higher than DBV Technologies SA's net income of -$33M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 134.93x while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.25x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.25x 134.93x $5B $219.7M DBVTDBV Technologies SA-- -- -- -$33M
-
Which has Higher Returns PHG or PRQR?
ProQR Therapeutics NV has a net margin of 5.53% compared to Koninklijke Philips NV's net margin of -381.88%. Koninklijke Philips NV's return on equity of 1.55% beat ProQR Therapeutics NV's return on equity of -67.34%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV46.36% $0.22 $22.1B PRQRProQR Therapeutics NV76.72% -$0.12 $84.2M -
What do Analysts Say About PHG or PRQR?
Koninklijke Philips NV has a consensus price target of $33.40, signalling upside risk potential of 26.09%. On the other hand ProQR Therapeutics NV has an analysts' consensus of $8.88 which suggests that it could grow by 322.62%. Given that ProQR Therapeutics NV has higher upside potential than Koninklijke Philips NV, analysts believe ProQR Therapeutics NV is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV0 2 0 PRQRProQR Therapeutics NV7 0 0 -
Is PHG or PRQR More Risky?
Koninklijke Philips NV has a beta of 0.793, which suggesting that the stock is 20.74% less volatile than S&P 500. In comparison ProQR Therapeutics NV has a beta of 0.176, suggesting its less volatile than the S&P 500 by 82.397%.
-
Which is a Better Dividend Stock PHG or PRQR?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.65%. ProQR Therapeutics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays 0.12% of its earnings as a dividend. ProQR Therapeutics NV pays out -- of its earnings as a dividend. Koninklijke Philips NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PHG or PRQR?
Koninklijke Philips NV quarterly revenues are $5B, which are larger than ProQR Therapeutics NV quarterly revenues of $3.4M. Koninklijke Philips NV's net income of $219.7M is higher than ProQR Therapeutics NV's net income of -$12.9M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 134.93x while ProQR Therapeutics NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.25x versus 12.70x for ProQR Therapeutics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.25x 134.93x $5B $219.7M PRQRProQR Therapeutics NV12.70x -- $3.4M -$12.9M
-
Which has Higher Returns PHG or QURE?
uniQure NV has a net margin of 5.53% compared to Koninklijke Philips NV's net margin of -2175.87%. Koninklijke Philips NV's return on equity of 1.55% beat uniQure NV's return on equity of -382.35%.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV46.36% $0.22 $22.1B QUREuniQure NV-8.89% -$1.38 $760.4M -
What do Analysts Say About PHG or QURE?
Koninklijke Philips NV has a consensus price target of $33.40, signalling upside risk potential of 26.09%. On the other hand uniQure NV has an analysts' consensus of $55.30 which suggests that it could grow by 131.1%. Given that uniQure NV has higher upside potential than Koninklijke Philips NV, analysts believe uniQure NV is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV0 2 0 QUREuniQure NV9 2 0 -
Is PHG or QURE More Risky?
Koninklijke Philips NV has a beta of 0.793, which suggesting that the stock is 20.74% less volatile than S&P 500. In comparison uniQure NV has a beta of 0.586, suggesting its less volatile than the S&P 500 by 41.431%.
-
Which is a Better Dividend Stock PHG or QURE?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.65%. uniQure NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays 0.12% of its earnings as a dividend. uniQure NV pays out -- of its earnings as a dividend. Koninklijke Philips NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PHG or QURE?
Koninklijke Philips NV quarterly revenues are $5B, which are larger than uniQure NV quarterly revenues of $3.7M. Koninklijke Philips NV's net income of $219.7M is higher than uniQure NV's net income of -$80.5M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 134.93x while uniQure NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.25x versus 81.77x for uniQure NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.25x 134.93x $5B $219.7M QUREuniQure NV81.77x -- $3.7M -$80.5M
-
Which has Higher Returns PHG or TRIB?
Trinity Biotech Plc has a net margin of 5.53% compared to Koninklijke Philips NV's net margin of -31.41%. Koninklijke Philips NV's return on equity of 1.55% beat Trinity Biotech Plc's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PHGKoninklijke Philips NV46.36% $0.22 $22.1B TRIBTrinity Biotech Plc35.03% -$0.46 $55.5M -
What do Analysts Say About PHG or TRIB?
Koninklijke Philips NV has a consensus price target of $33.40, signalling upside risk potential of 26.09%. On the other hand Trinity Biotech Plc has an analysts' consensus of -- which suggests that it could grow by 1497.96%. Given that Trinity Biotech Plc has higher upside potential than Koninklijke Philips NV, analysts believe Trinity Biotech Plc is more attractive than Koninklijke Philips NV.
Company Buy Ratings Hold Ratings Sell Ratings PHGKoninklijke Philips NV0 2 0 TRIBTrinity Biotech Plc0 0 0 -
Is PHG or TRIB More Risky?
Koninklijke Philips NV has a beta of 0.793, which suggesting that the stock is 20.74% less volatile than S&P 500. In comparison Trinity Biotech Plc has a beta of 0.489, suggesting its less volatile than the S&P 500 by 51.129%.
-
Which is a Better Dividend Stock PHG or TRIB?
Koninklijke Philips NV has a quarterly dividend of $0.97 per share corresponding to a yield of 3.65%. Trinity Biotech Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Koninklijke Philips NV pays 0.12% of its earnings as a dividend. Trinity Biotech Plc pays out -- of its earnings as a dividend. Koninklijke Philips NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PHG or TRIB?
Koninklijke Philips NV quarterly revenues are $5B, which are larger than Trinity Biotech Plc quarterly revenues of $15.2M. Koninklijke Philips NV's net income of $219.7M is higher than Trinity Biotech Plc's net income of -$4.8M. Notably, Koninklijke Philips NV's price-to-earnings ratio is 134.93x while Trinity Biotech Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Koninklijke Philips NV is 1.25x versus 0.22x for Trinity Biotech Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PHGKoninklijke Philips NV1.25x 134.93x $5B $219.7M TRIBTrinity Biotech Plc0.22x -- $15.2M -$4.8M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 24.85% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is down 19.66% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is down 16.08% over the past day.
